Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang

Cardiovascular disease (CVD) is a major cause of death in China

Abstract

Despite government efforts, the majority of hypertensive and diabetic patients in China do not receive proper treatment. Reducing CVD events requires long-term care that is proactive, patient-centred, community-based, and sustainable. The authors designed a package of interventions for patients at high risk of CVD to be implemented by family doctors based in township hospitals (providers of primary care) in rural Zhejiang, China. This trial aims to determine whether the systematic CVD risk reduction package results in reduced CVD events among patients at risk of CVD compared with usual care, and whether the package is cost-effective and suitable for routine implementation and scale-up.

This research is supported by the Department for International Development’s COMDIS–HSD Programme which is led by the University of Leeds

Citation

Wei XiaoLin; Zou GuanYang; Gong WeiWei; Jia Yin; Yu YunXian; Walley, J.; Zhang ZhiTon; King, R.; Kun Chen; Chong, M.K.C.; Yee, B.C.Y.; Su Liu; Tang JinLing; Griffiths, S.; Min Yu. Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang. Trials (2013) 14 (1) 354. [DOI: 10.1186/1745-6215-14-354]

Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang

Published 25 October 2013